Skip to main content
. 2018 Nov 13;11:8045–8052. doi: 10.2147/OTT.S178431

Table 1.

lncRNAs related to NSCLC diagnosis

lncRNA Diagnostic efficacy Reference

MALAT1 Circulating MALAT1, AUC=0.79 21
Exosomal MALAT1, AUC=0.703 22
GAS5 Circulating GAS5, AUC=0.832 25
Combination of GAS5 and CEA, AUC=0.909
XIST and HIF1A-AS1 Circulating XIST, AUC=0.834 26
Circulating HIF1A-AS1, AUC=0.876
Combination of XIST and HIF1A-AS1, AUC=0.931
SPRY4-IT1, ANRIL, and NEAT1 Circulating SPRY4-IT1, AUC=0.603 27
Circulating ANRIL, AUC=0.798
Circulating NEAT1, AUC=0.693
Combination of SPRY4-IT1, ANRIL, and NEAT1; AUC=0.876
SOX2OT and ANRIL Circulating SOX2OT, AUC=0.745 28
Circulating ANRIL, AUC=0.723
Combination of SOX2OT, ANRIL, CEA, CYFRA21-1, and SCCA; AUC=0.853

Abbreviations: AUC, area under the receiver operating characteristic curve; NSCLC, non-small cell lung cancer; CEA, carcinoembryonic antigen.